Author(s): de Boer HD, van Esmond J, Booij LH, Driessen JJ
Abstract Share this page
Abstract A case is reported in which a child with Duchenne muscular dystrophy received a dose of sugammadex to reverse a rocuronium-induced profound neuromuscular block. Sugammadex is the first selective relaxant binding agent and reverses rocuronium- and vecuronium-induced neuromuscular block. A fast and efficient recovery from profound neuromuscular block was achieved, and no adverse events or other safety concerns were observed.
This article was published in Paediatr Anaesth
and referenced in Journal of Anesthesia & Clinical Research